10x Genomics is an American Biotech company that specializes in designing and manufacturing of gene sequencing technology that is used for scientific research purposes and clinical diagnostics. The firm has unfolded its plans to generate $100 million through an initial public offering (IPO), according to the Security Exchange Commission. The company is situated in Pleasanton, and it plans to list on the Nasdaq under the symbol TXG. The biotech firm is a developer of integrate